Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck Serono

Showing 15 posts of 72 posts found.

Belén Garijo image

Merck makes big changes at the top

October 1, 2013
Medical Communications, Sales and Marketing Merck, Merck Serono

Merck has reshuffled its leadership as Belén Garijo is appointed to be its new president and chief executive of Merck …

News
Roche image

Roche cancer treatment shows promise

September 30, 2013
Sales and Marketing MPDL3280A, Merck Serono, NSCLC, Roche

An early-stage oncology treatment has shown encouraging results in smokers with lung cancer, Roche has said in a presentation at …

News
merck serono image

Merck Serono won’t give up on cancer vaccine

September 26, 2013
Sales and Marketing Merck, Merck Serono, Stimuvax

Merck Serono’s once failed lung cancer vaccine treatment Stimuvax has been given a second chance as the German firm begins …

News

Merck Serono sets up cancer platform

July 3, 2013
Research and Development, Sales and Marketing Cancer, Cladribine, Merck Serono, kgaa

Merck Serono is attempting to speed up R&D on products which stimulate the immune system to fight cancer by establishing …

News
Merck Serono image

Merck Serono censured over calls

June 25, 2013
Medical Communications, Sales and Marketing ABPI, Erbitux, Merck Serono, PMCPA

A Merck Serono medical representative has been accused of ‘harassing’ an anonymous health professional by requesting a meeting every month …

News
merck serono image

Merck signs lupus research deal

January 30, 2013
Research and Development, Sales and Marketing Feinstein, Merck Serono, SLE

Merck Serono and the Feinstein Institute for Medical Research in New York are to collaborate on antibodies to treat systemic …

News

Merck Serono has redeployed a fifth of axed Swiss staff

October 2, 2012
Manufacturing and Production Geneva, Merck Serono

Merck Serono says it has redeployed 260 of 1,250 staff affected by the closure and downsizing of sites in Switzerland …

News
merck serono image

Merck Serono says dispute over Geneva closure is resolved

August 10, 2012
Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts

Merck Serono says it has reached agreement with groups representing workers affected by the closure and downsizing of sites in …

News

Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops

July 30, 2012
Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss

A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …

News
erbitux image

Erbitux fails in gastric cancer trial

July 6, 2012
Research and Development, Sales and Marketing Erbitux, Merck Serono, Roche, failure, gastric cancer

Merck’s Erbitux has failed to increase survival in patients with gastric cancer, representing a blow to the firm’s ambition to …

News
screen_shot_2012-07-04_at_10

New head at the European Medicines Agency

July 4, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Merck Serono, Stallergenes

Merck Serono’s Enrica Alteri has been appointed by The European Medicines Agency as its new head of Safety and Efficacy …

Appointment

Quintiles offers lifeline to Merck Serono employees

June 28, 2012
Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts, manufacturing

Quintiles has said it will make at least 100 job offers within the next three months to workers set to …

News
Workers 'flash mob' outside Merck Serono HQ

Merck Serono tweaks Swiss restructuring plans

June 20, 2012
Manufacturing and Production, Sales and Marketing Merck Serono, cuts, restructuring

Merck KGaA has finalised the restructuring plans at Swiss drugs unit Merck Serono, confirming that it intends to close its …

News

Merck Serono staff may strike over Geneva HQ closure

June 6, 2012
Manufacturing and Production, Research and Development ASCO, Basel, Geneva, Merck Serono, Novartis, R&D

Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …

News
Erbitux image

Merck KGaA’s colon cancer drug fails trial

May 16, 2012
Research and Development, Sales and Marketing Erbitux, Merck KGaA, Merck Serono, colon cancer

Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial.  …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026